he conformational antibody A11 recognizes the structural similarity of peptide 1 and toxic oligomers of various amyloidogenic proteins (38). At and above stoichiometric concentrations, peptide 1 was shown to engage soluble and low molecular weight Aβ species, modulate aggregation, disassemble fibrils, and inhibit cell toxicity by an “off-pathway” mechanism